Report Detail
Global Glial Cell Line Derived Neurotrophic Factor Market Insights, Forecast to 2025
- RnM2850100 |
- 01 February, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
The global Glial Cell Line Derived Neurotrophic Factor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glial Cell Line Derived Neurotrophic Factor market based on company, product type, end user and key regions.
This report studies the global market size of Glial Cell Line Derived Neurotrophic Factor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glial Cell Line Derived Neurotrophic Factor in these regions.
This research report categorizes the global Glial Cell Line Derived Neurotrophic Factor market by top players/brands, region, type and end user. This report also studies the global Glial Cell Line Derived Neurotrophic Factor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline Plc
Treeway BV
UniQure NV
Market size by Product
GSK-812
LAUR-301
TW-002
AMT-090
Others
Market size by End User
Amyotrophic Lateral Sclerosis
Brain Ischemia
Parkinson's Disease
Retinal Degeneration
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Glial Cell Line Derived Neurotrophic Factor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Glial Cell Line Derived Neurotrophic Factor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Glial Cell Line Derived Neurotrophic Factor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Glial Cell Line Derived Neurotrophic Factor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Glial Cell Line Derived Neurotrophic Factor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glial Cell Line Derived Neurotrophic Factor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Glial Cell Line Derived Neurotrophic Factor Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by Product
- 1.4.2 GSK-812
- 1.4.3 LAUR-301
- 1.4.4 TW-002
- 1.4.5 AMT-090
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by End User
- 1.5.2 Amyotrophic Lateral Sclerosis
- 1.5.3 Brain Ischemia
- 1.5.4 Parkinson's Disease
- 1.5.5 Retinal Degeneration
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size
- 2.1.1 Global Glial Cell Line Derived Neurotrophic Factor Revenue 2014-2025
- 2.1.2 Global Glial Cell Line Derived Neurotrophic Factor Sales 2014-2025
- 2.2 Glial Cell Line Derived Neurotrophic Factor Growth Rate by Regions
- 2.2.1 Global Glial Cell Line Derived Neurotrophic Factor Sales by Regions
- 2.2.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Glial Cell Line Derived Neurotrophic Factor Sales by Manufacturers
- 3.1.1 Glial Cell Line Derived Neurotrophic Factor Sales by Manufacturers
- 3.1.2 Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Manufacturers
- 3.1.3 Global Glial Cell Line Derived Neurotrophic Factor Market Concentration Ratio (CR5 and HHI)
- 3.2 Glial Cell Line Derived Neurotrophic Factor Revenue by Manufacturers
- 3.2.1 Glial Cell Line Derived Neurotrophic Factor Revenue by Manufacturers (2014-2019)
- 3.2.2 Glial Cell Line Derived Neurotrophic Factor Revenue Share by Manufacturers (2014-2019)
- 3.3 Glial Cell Line Derived Neurotrophic Factor Price by Manufacturers
- 3.4 Glial Cell Line Derived Neurotrophic Factor Manufacturing Base Distribution, Product Types
- 3.4.1 Glial Cell Line Derived Neurotrophic Factor Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Glial Cell Line Derived Neurotrophic Factor Product Type
- 3.4.3 Date of International Manufacturers Enter into Glial Cell Line Derived Neurotrophic Factor Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Glial Cell Line Derived Neurotrophic Factor Sales by Product
- 4.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue by Product
- 4.3 Glial Cell Line Derived Neurotrophic Factor Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Glial Cell Line Derived Neurotrophic Factor Breakdown Data by End User
6 North America
- 6.1 North America Glial Cell Line Derived Neurotrophic Factor by Countries
- 6.1.1 North America Glial Cell Line Derived Neurotrophic Factor Sales by Countries
- 6.1.2 North America Glial Cell Line Derived Neurotrophic Factor Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Glial Cell Line Derived Neurotrophic Factor by Product
- 6.3 North America Glial Cell Line Derived Neurotrophic Factor by End User
7 Europe
- 7.1 Europe Glial Cell Line Derived Neurotrophic Factor by Countries
- 7.1.1 Europe Glial Cell Line Derived Neurotrophic Factor Sales by Countries
- 7.1.2 Europe Glial Cell Line Derived Neurotrophic Factor Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Glial Cell Line Derived Neurotrophic Factor by Product
- 7.3 Europe Glial Cell Line Derived Neurotrophic Factor by End User
8 Asia Pacific
- 8.1 Asia Pacific Glial Cell Line Derived Neurotrophic Factor by Countries
- 8.1.1 Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales by Countries
- 8.1.2 Asia Pacific Glial Cell Line Derived Neurotrophic Factor Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Glial Cell Line Derived Neurotrophic Factor by Product
- 8.3 Asia Pacific Glial Cell Line Derived Neurotrophic Factor by End User
9 Central & South America
- 9.1 Central & South America Glial Cell Line Derived Neurotrophic Factor by Countries
- 9.1.1 Central & South America Glial Cell Line Derived Neurotrophic Factor Sales by Countries
- 9.1.2 Central & South America Glial Cell Line Derived Neurotrophic Factor Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Glial Cell Line Derived Neurotrophic Factor by Product
- 9.3 Central & South America Glial Cell Line Derived Neurotrophic Factor by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor by Countries
- 10.1.1 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales by Countries
- 10.1.2 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor by Product
- 10.3 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor by End User
11 Company Profiles
- 11.1 GlaxoSmithKline Plc
- 11.1.1 GlaxoSmithKline Plc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Products Offered
- 11.1.5 GlaxoSmithKline Plc Recent Development
- 11.2 Treeway BV
- 11.2.1 Treeway BV Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Treeway BV Glial Cell Line Derived Neurotrophic Factor Products Offered
- 11.2.5 Treeway BV Recent Development
- 11.3 UniQure NV
- 11.3.1 UniQure NV Company Details
- 11.3.2 Company Business Overview
- 11.3.3 UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 UniQure NV Glial Cell Line Derived Neurotrophic Factor Products Offered
- 11.3.5 UniQure NV Recent Development
12 Future Forecast
- 12.1 Glial Cell Line Derived Neurotrophic Factor Market Forecast by Regions
- 12.1.1 Global Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Regions 2019-2025
- 12.1.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Regions 2019-2025
- 12.2 Glial Cell Line Derived Neurotrophic Factor Market Forecast by Product
- 12.2.1 Global Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Product 2019-2025
- 12.2.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Product 2019-2025
- 12.3 Glial Cell Line Derived Neurotrophic Factor Market Forecast by End User
- 12.4 North America Glial Cell Line Derived Neurotrophic Factor Forecast
- 12.5 Europe Glial Cell Line Derived Neurotrophic Factor Forecast
- 12.6 Asia Pacific Glial Cell Line Derived Neurotrophic Factor Forecast
- 12.7 Central & South America Glial Cell Line Derived Neurotrophic Factor Forecast
- 12.8 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Glial Cell Line Derived Neurotrophic Factor Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Glial Cell Line Derived Neurotrophic Factor . Industry analysis & Market Report on Glial Cell Line Derived Neurotrophic Factor is a syndicated market report, published as Global Glial Cell Line Derived Neurotrophic Factor Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Glial Cell Line Derived Neurotrophic Factor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
